Michael Silpa
Berkeley, CANPI 1679684195
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 168 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. 2021 is the largest year on record at $1,515, 2.3 times the $665 reported in 2019.
Across 168 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$718
- Johnson & Johnson$658
- Takeda Pharmaceuticals U.S.A., Inc.$470
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$229
- Merck$180
- Ferring Pharmaceuticals Inc.$117
- plus $735 from 13 others
What the payments were for
- Food & beverage$3,08799%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 45 | $718 |
| Johnson & Johnson | 46 | $658 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $470 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $229 |
| Merck | 5 | $180 |
| Ferring Pharmaceuticals Inc. | 7 | $117 |
| Pfizer | 5 | $116 |
| Dova Pharmaceuticals | 1 | $113 |
| Daiichi Sankyo Inc. | 5 | $110 |
| Janssen Scientific Affairs, LLC | 1 | $105 |
| Intercept Pharmaceuticals, Inc. | 5 | $87 |
| Gilead | 2 | $67 |
| Concordia Pharmaceuticals Inc. | 2 | $39 |
| Braintree Laboratories, Inc. | 1 | $23 |
| Shionogi Inc | 1 | $20 |
| Bristol Myers Squibb | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Lexicon Pharmaceuticals, Inc. | 1 | $13 |
| Napo Pharmaceuticals Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.